Patent details

Basic Information

Publication number:

EP1609781

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP050154616

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine

French Title of Invention:

Méthode pour la résolution optique de (1-benzyl-4-méthylpiperidin-3-yl)-méthylamine

German Title of Invention:

Racemattrennung von (1-Benzyl-4-methylpiperidin-3-yl)-methylamin

SPC Number:

Dates

Filing date:

29/05/2002

Grant date:

10/08/2011

EP Publication Date:

10/08/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/12/2005

EP B1 Publication Date:

10/08/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/05/2012

Expiration date:

29/05/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/05/2002

 

 

Name:

Pfizer Products Inc.

Address:

Eastern Point Road, Groton, CT 06340, United States (US)

Inventor

1

Name:

Wilcox Glenn Ernest, Pfizer Global Research

Address:

United States (US)

2

Name:

Koecher Christian

Address:

Switzerland (CH)

3

Name:

Munchhof Michael John, Pfizer Global Research

Address:

United States (US)

4

Name:

Flanagan Mark Edwards, Pfizer Global Research

Address:

United States (US)

5

Name:

Vries Ton

Address:

Netherlands (NL)

Priority

1

Priority Number:

294775 P

Priority Date:

31/05/2001

Priority Country:

United States (US)

2

Priority Number:

341048 P

Priority Date:

06/12/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 211/56;

Filing date	Document type	Number of pages